科言猫
学术研究的AI总结
首页
文献互助
订阅
我的收藏
科研工具
选题分析
论文总结
专利管理
未登录
返回
期刊详情
Current Hematologic Malignancy Reports
IF
3.3
论文数
55
被引数
1303
相关解读
0
订阅
期刊论文
55
相关解读
0
期刊论文
55
发表时间
发表时间
IF
被引数
Strategies to Overcome Inequities in the Treatment of Patients with Hematologic Malignancies
克服血液系统恶性肿瘤患者治疗中不平等的策略
Current Hematologic Malignancy Reports
IF
3.3
2026-09-11
0
PRE
AI
Carlos de la Cruz-de la Cruz; Yessica M. González-Mártinez; Andrés Gómez-De León
分享
收藏
Real World Data and Its Impact on the Management of Plasma Cell Dyscrasias
真实世界数据及其对浆细胞异常增殖性疾病管理的影响
Current Hematologic Malignancy Reports
IF
3.3
2026-08-29
0
PRE
AI
Naveen Subramanian; Samuel M. Rubinstein
分享
收藏
Linking Air Pollution and Hematologic Malignancies: From Epidemiology to Molecular Mechanisms
将空气污染与血液系统恶性肿瘤联系起来:从流行病学到分子机制
Current Hematologic Malignancy Reports
IF
3.3
2026-08-11
0
OA
AI
Hamsa Murli; Sadia Alam; Evelyn Mesler; Aditi Shastri
分享
收藏
Antigen Pressure, Clonal Evolution, and Lineage Plasticity in B-Cell Acute Lymphoblastic Leukemia: Resistance Biology in the Immunotherapy Era
抗原压力、克隆进化和谱系可塑性在B细胞急性淋巴细胞白血病中的作用:免疫治疗时代的耐药生物学
Current Hematologic Malignancy Reports
IF
3.3
2026-08-07
0
PRE
AI
Julio Alvarenga Thiebaud; Tamer Othman; Ibrahim Aldoss
分享
收藏
Beyond Survival: Measuring Treatment Tolerability with Patient-Reported Outcomes in the Lymphoma Immunotherapy Era
超越生存:在淋巴瘤免疫治疗时代,利用患者报告结局评估治疗耐受性
Current Hematologic Malignancy Reports
IF
3.3
2026-08-07
0
PRE
AI
Elisa Hofmeister; Ajay Major
分享
收藏
Chronic Myelomonocytic Leukemia: History, Pathobiology, Diagnostic Controversies, and Evolving Classification
慢性骨髓单核细胞白血病:历史、病理生物学、诊断争议及演变中的分类
Current Hematologic Malignancy Reports
IF
3.3
2026-08-03
0
OA
AI
Sanam Loghavi; Robert P. Hasserjian
分享
收藏
Breaching the Blood-Brain Barrier: Evolving Strategies for Central Nervous System Disease in Adult Acute Lymphoblastic Leukemia
突破血脑屏障:成人急性淋巴细胞白血病中枢神经系统疾病的治疗策略演变
Current Hematologic Malignancy Reports
IF
3.3
2026-07-13
0
OA
AI
Liesl S. Eibschutz; Samuel Crow; Caroline Tatum; Daniel Reed; Michael Keng
分享
收藏
Correction: Clonal Signatures of Telomere Biology Disorders
更正:克隆特征与端粒生物学障碍
Current Hematologic Malignancy Reports
IF
3.3
2026-07-10
0
PRE
AI
Luca Arcuri; Emma M. Groarke; Sharon A. Savage; Fernanda Gutierrez-Rodrigues
分享
收藏
BRAF Alterations in Chronic Lymphocytic Leukemia: Genomic Landscape, Co-Mutation Patterns, and Clinical Relevance
慢性淋巴细胞白血病的BRAF基因突变:基因组景观、共突变模式及其临床相关性
Current Hematologic Malignancy Reports
IF
3.3
2026-05-01
0
OA
AI
Abdulrahman Al-Abdulmalek; Eric Landry; Mohammed Abdulgayoom; Abdulrahman F. Al-Mashdali; Ayman Abdullah Dalol; Bassam Muthanna; Jean-Pierre Routy; Shehab F. Mohamed
分享
收藏
Targeting the BCR::ABL1 Kinase: Advances Beyond Imatinib in Chronic Myeloid Leukemia
靶向BCR::ABL1激酶:慢性粒细胞白血病中伊马替尼之外的进展
Current Hematologic Malignancy Reports
IF
3.3
2026-04-25
0
PRE
AI
Zuhal Naderi; Teresa Sadras; Susan Branford; Naranie Shanmuganathan; Ilaria S. Pagani
分享
收藏
Germline DDX41 Variants: Current Understanding and Future Directions
生殖系DDX41变异:当前理解与未来方向
Current Hematologic Malignancy Reports
IF
3.3
2026-04-23
0
PRE
AI
Aldo A. Acosta-Medina; Abhishek A. Mangaonkar
分享
收藏
Clonal Signatures of Telomere Biology Disorders
端粒生物学疾病的克隆性特征
Current Hematologic Malignancy Reports
IF
3.3
2026-04-14
0
OA
AI
Luca Arcuri; Emma M. Groarke; Sharon A. Savage; Fernanda Gutierrez-Rodrigues
分享
收藏
Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms
骨髓增殖性高嗜酸性粒细胞肿瘤的分子发病机制与靶向治疗
Current Hematologic Malignancy Reports
IF
3.3
2026-03-07
0
OA
AI
Colette Hanna; Joe Rizkallah; Nicole Charbel; Shereen Sakkal; Fadi G. Haddad
分享
收藏
The Intricate Dance Between Inflammation and Myeloproliferative Neoplasms: From Origins to Outcomes
炎症与骨髓增殖性肿瘤之间错综复杂的关系:从起源到结局
Current Hematologic Malignancy Reports
IF
3.3
2026-03-06
0
OA
AI
Angela G Fleischman
分享
收藏
When Targeted Therapy Falls Short: Unraveling Resistance Mechanisms in Chronic Lymphocytic Leukemia
当靶向治疗效果不佳时:解析慢性淋巴细胞白血病的耐药机制
Current Hematologic Malignancy Reports
IF
3.3
2026-02-26
0
OA
AI
Samon Benrashid; Jennifer A. Woyach
分享
收藏
Inotuzumab Ozogamicin in Clinical Practice: an Overview of Efficacy, Safety, and Real-World Applications
伊诺妥单抗奥扎胞苷在临床实践中的应用:疗效、安全性及真实世界应用的概述
Current Hematologic Malignancy Reports
IF
3.3
2026-02-24
0
OA
AI
Valerie Tran; Nandan Srinivasa; Caroline Tatum; Daniel Reed; Michael Keng
分享
收藏
New Approaches for Measurable Residual Disease Assessment in Multiple Myeloma: Integrating NGS, Mass Spectrometry, and Next-Generation Flow Cytometry to Monitor Treatment Response
新方法用于多发性骨髓瘤微小残留病灶评估:整合NGS、质谱技术和下一代流式细胞术监测治疗反应
Current Hematologic Malignancy Reports
IF
3.3
2026-02-14
0
PRE
AI
Bhavesh Mohan Lal; Shaji K. Kumar
分享
收藏
The Role and Impact of Non-driver Gene Mutations in Myelofibrosis
非驱动基因突变在骨髓纤维化中的作用和影响
Current Hematologic Malignancy Reports
IF
3.3
2026-02-10
0
OA
AI
Valentina Boldrini; Paola Guglielmelli; Alessandro M. Vannucchi
分享
收藏
Advances and Controversies in the Management of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Navigating First-Line Therapies
Current Hematologic Malignancy Reports
IF
3.3
2026-02-03
0
PRE
AI
Talia Zahra; Nadia Bambace; Lyle Feinstein; Charbel El Chaer; Yara Kadi; Michael A. Lezcano; Yenlys Vega; Tiba Al-Sagheer; Firas El Chaer
分享
收藏
Understanding Triple Negative Myeloproliferative Neoplasms and Identifying Molecular Drivers
Current Hematologic Malignancy Reports
IF
3.3
2026-01-15
0
PRE
AI
Valentina Boldrini; Giuseppe G. Loscocco; Paola Guglielmelli; Naseema Gangat; Alessandro M. Vannucchi; Ayalew Tefferi
分享
收藏